Searched for
ANTI TB DRUG
Plans to restrict open market access to tuberculosis medicinesIndia is tightening access to anti-TB drugs Bedaquiline and Delamanid due to rising drug-resistant tuberculosis cases and potential misuse ...- Pharma cos can supply generic Bedaquiline to other countriesMultinational pharmaceutical company Johnson & Johnson (J&J) has announced that it will not enforce secondary patents for its anti-TB drug ...
- No shortage of anti-TB drugs in India, asserts Health MinistryThe treatment regimen of multi drug resistant TB consists of usually four months of seven drugs (bedaquiline, levofloxacin, clofazimine, is...
- J&J, Lupin cut prices for tuberculosis drug in lower-income countriesJohnson & Johnson and Lupin will supply their versions of the tuberculosis drug bedaquiline at a significantly cheaper price in low- and mi...
- Getting patented meds on NLEM list an uphill battle says committee memberAs many as 34 new drugs were added and 26 dropped from an updated list of essential medicines.For the first time patented drugs like anti-T...
- Lupin, TB Alliance join hands for new therapy for drug-resistant tuberculosisTB Alliance President and CEO Mel Spigelman said that partnering with Lupin -- a well-established manufacturer with experience delivering h...
- Government slashes prices of about 39 commonly-used drugsThe drugs brought under price control include teneligliptin-an anti diabetes drug, popular anti TB drugs like Bedaquiline and Delamanid, Iv...
- Mylan gets DCGI nod for anti-tuberculosis drug Pretomanid for conditional accessThe Drug Controller General of India (DCGI) has approved Pretomanid for conditional access under the National Tuberculosis Elimination Prog...
- Export of anti-tuberculosis medicines a worryThe health ministry has flagged the need for suspension of the export of anti-tuberculosis medicines, saying the coronavirus outbreak has i...
- Mumbai pharma company gets licence for breakthrough TB drugA global non-profit drug developer TB Alliance has tied up with domestic company Macleods Pharmaceuticals to develop and commercialise its ...
- Mylan working with DCGI to launch new TB drug in IndiaMylan will be in a position to launch the product in India soon after receiving approvals from DCGI," Mylans global president and executive...
- World TB Day: Over 25% TB patients in India are resistant to at least one anti-TB drug"High rates of treatment failure and deaths are associated with fluoroquinolone resistance in the Indian cohort of MDR-TB patients," stated...
- Indian scientists provide new insights for tuberculosis drug discoveryThe TB bacterium is cunning and is able to survive according to the researchers due to its ability to sense and adapt to its host's environ...
- Government launches new medicine to treat drug resistant TBAhead of World Tuberculosis Day on March 24, government today launched Bedaquiline, a new class of anti-tuberculosis medicine discovered to...
- New compound may treat HIV, drug-resistant TBResearchers, including one of Indian-origin, have developed a new molecule that may treat multi-drug resistant tuberculosis and even HIV in...
- Anti-diabetic drug may help treat tuberculosis: StudyEven though drugs are available to treat the disease, TB continues to be a major threat to public health, killing close to 1.5 million peop...
- TB a national emergency: Health Minister Harsh VardhanVardhan said that an email repository will be built up for establishing connectivity between govt & all doctors in the country to help figh...
- Need to address drug-resistant TB cases in India: Union Health SecretaryIndia accounts for nearly one-fourth of global incidence of TB and public health officials here are working on finding a cure for drug-resi...
- New drug-resistant TB strain poses threat to IndiaIndia has a major health challenge on its hands, figuring second on the list of countries with the largest concentration of people sufferin...
- Two new TB drugs enter advanced stages of clinical trialTwo new drugs against tuberculosis have reached the advanced stages of clinical trial and could be made available for use by 2012-2014.
Load More
